Fluoxetin Viatris 20 mg Kapsel, hård Sverige - svenska - Läkemedelsverket (Medical Products Agency)

fluoxetin viatris 20 mg kapsel, hård

viatris limited - fluoxetinhydroklorid - kapsel, hård - 20 mg - laktosmonohydrat hjälpämne; propylenglykol hjälpämne; fluoxetinhydroklorid 22,36 mg aktiv substans - fluoxetin

Pirfenidone Viatris Europeiska unionen - svenska - EMA (European Medicines Agency)

pirfenidone viatris

viatris limited - pirfenidon - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunsuppressiva - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Dapagliflozin Viatris Europeiska unionen - svenska - EMA (European Medicines Agency)

dapagliflozin viatris

viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - läkemedel som används vid diabetes - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 och 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.

Lipanthyl 200 mg Kapsel, hård Sverige - svenska - Läkemedelsverket (Medical Products Agency)

lipanthyl 200 mg kapsel, hård

viatris ab - fenofibrat - kapsel, hård - 200 mg - fenofibrat 200 mg aktiv substans; natriumlaurilsulfat hjälpämne; laktosmonohydrat hjälpämne - fenofibrat

Clopidogrel Viatris (previously Clopidogrel Taw Pharma) Europeiska unionen - svenska - EMA (European Medicines Agency)

clopidogrel viatris (previously clopidogrel taw pharma)

viatris limited - klopidogrelbesilat - peripheral vascular diseases; stroke; myocardial infarction - antitrombotiska medel - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). st-segmentet höjd akut hjärtinfarkt, i kombination med asa i medicinskt behandlade patienter berättigade till trombolysbehandling. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. för ytterligare information hänvisas till avsnitt 5.

E-vimin 100 mg Kapsel, mjuk Sverige - svenska - Läkemedelsverket (Medical Products Agency)

e-vimin 100 mg kapsel, mjuk

viatris ab - all-rac-alfa-tokoferylacetat - kapsel, mjuk - 100 mg - glycerol hjälpämne; all-rac-alfa-tokoferylacetat 100 mg aktiv substans - tokoferol (vitamin e)

Epanutin 100 mg Kapsel, hård Sverige - svenska - Läkemedelsverket (Medical Products Agency)

epanutin 100 mg kapsel, hård

viatris ab - fenytoinnatrium - kapsel, hård - 100 mg - laktosmonohydrat hjälpämne; natriumlaurilsulfat hjälpämne; fenytoinnatrium 100 mg aktiv substans; propylenglykol hjälpämne - fenytoin

Lipanthyl 200 mg Kapsel, hård Sverige - svenska - Läkemedelsverket (Medical Products Agency)

lipanthyl 200 mg kapsel, hård

2care4 aps - fenofibrat - kapsel, hård - 200 mg - natriumlaurilsulfat hjälpämne; laktosmonohydrat hjälpämne; fenofibrat 200 mg aktiv substans

Celebra 200 mg Kapsel, hård Sverige - svenska - Läkemedelsverket (Medical Products Agency)

celebra 200 mg kapsel, hård

2care4 aps - celecoxib - kapsel, hård - 200 mg - laktosmonohydrat hjälpämne; natriumlaurilsulfat hjälpämne; celecoxib 200 mg aktiv substans - celecoxib

Esomeprazol Viatris 20 mg Enterokapsel, hård Sverige - svenska - Läkemedelsverket (Medical Products Agency)

esomeprazol viatris 20 mg enterokapsel, hård

viatris limited - esomeprazolmagnesium - enterokapsel, hård - 20 mg - natriumlaurilsulfat hjälpämne; propylenglykol hjälpämne; sackaros hjälpämne; esomeprazolmagnesium 22,252 mg aktiv substans; sockersfärer hjälpämne; mannitol hjälpämne - esomeprazol